Navigation Links
TU Delft tests windmill for seawater desalination
Date:2/29/2008

A traditional windmill which drives a pump: that is the simple concept behind the combination of windmill/reverse osmosis developed by the Delft University of Technology (TU Delft) in The Netherlands. In this case, it involves a high-pressure pump which pushes water through a membrane using approximately 60 bar. This reverse osmosis membrane produces fresh water from seawater directly. The windmill is suited for use by, for instance, small villages in isolated, dry coastal areas.

The combination of windmills and desalination installations is already commercially available. These windmills produce electricity from wind power, the electricity is stored and subsequently used to drive the high-pressure pump for the reverse osmosis installation. The storage of electricity in particular is very expensive. Energy is also lost during conversion.

In the TU Delft installation, the high-pressure pump is driven directly by wind power. Water storage can be used to overcome calm periods. The storage of water is after all a great deal cheaper than that of electricity.

Robust

The chosen windmill is normally used for irrigation purposes. These windmills turn relatively slowly and are also very robust. On the basis of the windmills capacity at varying wind speeds, it is estimated that it will produce 5 to 10 m3 of fresh water per day: enough drinking water for a small village of 500 inhabitants. A water reservoir will have to ensure that enough water is available for a calm period lasting up to five days. Three safeguards (in the event of the installation running dry, a low number of revolutions or a high number of revolutions) are also performed mechanically so that no electricity is needed.

Prototype

The first prototype has been built and is already working at a location near the A13 motorway near Delft. This prototype is to be dismantled and transported to Curaao the first week of March. There the conc
'/>"/>

Contact: Roy Meijer
r.e.t.meijer@tudelft.nl
31-152-781-751
Delft University of Technology
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Aussie neuroscientist tests addiction drug
2. Ongoing Tests Show Kona Kampachi(R) is Rich in Omega-3s With No Detectable Mercury
3. Love and Diabetes: dLife Valentines Day Quiz Tests and Teaches Important Relationship Lessons for People With Diabetes
4. New York Community Trust Awards Grant of $100,000 to Infectious Disease Research Institute for Early Detection Leprosy Tests
5. Lab on a chip developed at University of Alberta for cheap, portable medical tests
6. Mini stress tests could help condition heart to survive major attack
7. Bone Density Tests Do Predict Womens Fracture Risk
8. Cepheid and Broadlane Sign Group Purchasing Contract for GeneXpert(R) Systems and Xpert(TM) Molecular Diagnostic Tests, Including Xpert MRSA
9. Mayo Clinic tests novel vaccine for aggressive brain tumors
10. Gene Tests Match Up Lung Tumors, Best Treatment
11. K-State Veterinary Lab Routinely Tests For Bluetongue Virus; Lab Director Says Strains Found in Kansas, U.S. Usually Less-Virulent
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
TU Delft tests windmill for seawater desalination
TU Delft tests windmill for seawater desalination
Breaking Medicine Technology:Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Daniel K. Spiegelman Elected to Board of Directors of Omeros 2Its Time for More Moms to Breast Feed U S Officials Say 54480 1Its Time for More Moms to Breast Feed U S Officials Say 54480 2Its Time for More Moms to Breast Feed U S Officials Say 54480 3Little safe haven for sexually assaulted LGBTQ victims 54475 1Little safe haven for sexually assaulted LGBTQ victims 54475 2Little safe haven for sexually assaulted LGBTQ victims 54475 3Queen of Soul Foods Grandson on Mission to Get Harlem Kids to Eat Healthier 54472 1Queen of Soul Foods Grandson on Mission to Get Harlem Kids to Eat Healthier 54472 2Queen of Soul Foods Grandson on Mission to Get Harlem Kids to Eat Healthier 54472 3